Avanti® Polar Lipids 3D-(6-acyl) PHAD®

Merck KGaA, Darmstadt, Germany699855PAvailable: ,Western Europe,Asia,Eastern Europe,South Central America,Caribbean,Australia Oceania,Middle East,Africa,Other

Monophosphoryl Hexa-acyl Lipid A, 3-Deacyl (Synthetic), powder

Buy Now
Merck KGaA, Darmstadt, Germany

Place your order directly with the manufacturer.

Ease of Use
After Sales Service
Value for Money
Write your own review

Vaccination is well-accepted as an effective method to prevent infections by mounting pathogen-specific immune responses prior to the infection. Usually, immunization with vaccine antigens alone is not able to induce robust or long-lasting immune responses — resulting in failure of protective immunity against infections. Thus, adjuvants are required to enhance cellular or humoral immune responses upon immunization. Because vaccine adjuvants using Lipid A have proven to be safe and effective in inducing Th-1 type immune responses to heterologous proteins in animal and human vaccines, Avanti developed Phosphorylated HexaAcyl Disaccharide (PHAD®), the first fully synthetic monophosphoryl Lipid A available for use as an adjuvant in human vaccines.

Packaging

  • 2 mL Amber Glass Crimp Cap Vial (699855P-1mg)
  • 2 mL Amber Glass Crimp Cap Vial (699855P-5mg)

Other Notes

  • For R&D use only. Not for drug, household, or other uses.

Legal Information

PHAD is a registered trademark of Avanti Polar Lipids, Inc.

Product Overview

Links